Pricing Log in Create free account

Nyxoah SA (NYXH) vs Sera Prognostics, Inc. (SERA)

Nyxoah SA and Sera Prognostics, Inc. are both Medical Devices companies. Nyxoah SA and Sera Prognostics, Inc. are of similar size ($82.6M and $82.1M). Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 1.05%. Nyxoah SA has the higher net margin (−446.4% vs −34,866.7%) and the higher return on invested capital (−117.8% vs −278.6%). Across the 18 metrics below, Nyxoah SA leads on 12 and Sera Prognostics, Inc. on 6.

Valuation

Metric NYXH SERA Medical Devices median
P/E n/m n/m 25.58
P/S 1.84 1,100.45 2.54
P/B 0.48 2.01 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 0.06 641.21 2.72
Earnings yield (311.11%) (32.21%) (12.82%)
Free cash flow yield (187.33%) (27.81%) (8.18%)

Profitability

Metric NYXH SERA Medical Devices median
Gross margin 60.16% 0.00% 57.76%
Operating margin (391.25%) (38,755.21%) (15.07%)
Net margin (446.39%) (34,866.67%) (14.45%)
Free cash flow margin (344.99%) (30,198.96%) (3.88%)
Return on equity (124.41%) (49.73%) (10.35%)
Return on assets (68.23%) (35.59%) (17.26%)
Return on invested capital (117.82%) (278.58%) (5.27%)

Growth

Metric NYXH SERA Medical Devices median
Revenue growth (TTM) 366.24% 1.05% 10.41%
EPS growth (last fiscal year) (36.22%) 32.32% 28.17%
Revenue growth, 5-year CAGR 170.14% 26.51% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NYXH SERA Medical Devices median
Debt to equity 0.72 0.00 0.04
Current ratio 2.38 1.88 2.74
Net debt to EBITDA 0.08 1.10 0.54

Dividend

Metric NYXH SERA Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric NYXH SERA Medical Devices median
Market cap 82.59m 82.05m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack